Tissue Engineering and Regenerative Medicine (TERM) company. Aims to develop medical-grade regenerative biomaterials.

Combines advances in molecular cell biology and supercritical carbon dioxide extraction technology to remove lipids, cells, and non-collagenous proteins from tissues and organs to create natural collagen scaffolds suitable as xenograft biomaterials for TERM applications.